| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.8B | $8.5B | $7.8B | $8.3B | $8.4B | $5.6B | $5.8B | $6.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.4B | $1.1B | $1.8B | $1.9B | $1.0B | $1.6B | $2.1B |
| Net Income | $0.5B | $0.5B | $0.9B | $1.3B | $1.8B | $0.8B | $1.2B | $0.8B |
| EPS (Basic) | $0.91 | $0.85 | $1.72 | $2.53 | $3.58 | $1.59 | $2.35 | $1.39 |
| EPS (Diluted) | $0.91 | $0.85 | $1.72 | $2.53 | $3.57 | $1.59 | $2.35 | $1.39 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.4B | $32.5B | $30.1B | $28.1B | $24.2B | $20.2B | $14.5B | $14.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $4.6B | $4.0B | $6.0B | $6.9B |
| Total Liabilities | $18.2B | $17.9B | $16.5B | $14.2B | $11.4B | $8.7B | $3.2B | $3.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $12.1B | $12.5B | $11.9B | $11.5B | $11.2B | $10.1B | $9.9B | $9.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.0B | $1.1B | $2.0B | $1.2B | $1.0B | $0.2B | $2.2B |
| Investing Cash Flow | $-2.3B | $-2.4B | $-3.6B | $-3.3B | $-2.6B | $-3.2B | $-1.1B | $-0.3B |
| Capital Expenditures | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $0.5B | $1.4B | $2.0B | $1.6B | $2.0B | $0.2B | $-0.0B | $-3.8B |